Figure S3. TSLP mRNA isoform expression in CAFs in steady state conditions or after activation. For activation CAFs (n = 5) were treated with recombinant cytokines (IL-1α, IL-1β and TNF-α), which were used either alone or in combinations at the concentration of 20 ng/ml/each cytokine. a Expression of short and long TSLP forms by CAF untreated (basal) or activated by cytokine treatment (activated). b Fold (DOCX 191 kb) increase in TSLP mRNA expression after activation for the long and short TSLP isoforms. Significance was determined by the Wilcoxon matched-pairs signed rank test (a) and Mann Whitney test (b). Values significantly different were indicated as: p < 0.05. (DOCX 395 kb
Figure S4. Silencing TFAP2C inhibits proliferation ability of CRC cells. (A and B) Real-time PCR and...
Figure S1. Gastric cancer cell-derived conditioned medium induced pro-inflammatory factor gene expre...
Figure S2. PD-1 + CD137+ expression increases when αCSF-1R is administered before and after GVAX vac...
Figure S7. Proposed model of crosstalk within the tumor microenvironment leading to TSLP secretion b...
Figure S1. Validation of knockdown of IL-1α and IL-1β expression in Hs766T cells after siRNA transfe...
Figure S5. IL-1β expression in the stroma is mainly supported by TAMs. Immunofluorescence staining ...
Figure S2. Validation of knockdown of ASC/PYCARD expression in BxPC-3 and A8184 cells after siRNA tr...
Figure S3. Tumor-derived factor TNF-α induces mast cells to express PD-L1. (a) Expression of 2B4, gl...
Table S1. Comparison of levels of 27 cytokines in conditioned media from pancreatic cancer cells. Pa...
Figure S1. Representative photos of TG2-overexpressing MCF7 cells (MCF7_TG2) and control vector-tran...
Table S1. IHC Staining score of the expression levels of NLRP3 and IL-1β in 77 OSCC tissues. The pos...
Figure S11. Clinical relation of TFAP2C with Hippo signaling activity in human CRC tissues. (A) Anal...
Figure S4. Tumor-derived TNF-α activates NF-κB pathway to induce PD-L1 expression on mast cells. (a)...
Full list of author information is available at the end of the articleBackground Thymic stromal lymp...
TSG101 depletion leads to increased levels of MMP-9 mRNA in U2OS cells. (A) Depletion of TSG101 by s...
Figure S4. Silencing TFAP2C inhibits proliferation ability of CRC cells. (A and B) Real-time PCR and...
Figure S1. Gastric cancer cell-derived conditioned medium induced pro-inflammatory factor gene expre...
Figure S2. PD-1 + CD137+ expression increases when αCSF-1R is administered before and after GVAX vac...
Figure S7. Proposed model of crosstalk within the tumor microenvironment leading to TSLP secretion b...
Figure S1. Validation of knockdown of IL-1α and IL-1β expression in Hs766T cells after siRNA transfe...
Figure S5. IL-1β expression in the stroma is mainly supported by TAMs. Immunofluorescence staining ...
Figure S2. Validation of knockdown of ASC/PYCARD expression in BxPC-3 and A8184 cells after siRNA tr...
Figure S3. Tumor-derived factor TNF-α induces mast cells to express PD-L1. (a) Expression of 2B4, gl...
Table S1. Comparison of levels of 27 cytokines in conditioned media from pancreatic cancer cells. Pa...
Figure S1. Representative photos of TG2-overexpressing MCF7 cells (MCF7_TG2) and control vector-tran...
Table S1. IHC Staining score of the expression levels of NLRP3 and IL-1β in 77 OSCC tissues. The pos...
Figure S11. Clinical relation of TFAP2C with Hippo signaling activity in human CRC tissues. (A) Anal...
Figure S4. Tumor-derived TNF-α activates NF-κB pathway to induce PD-L1 expression on mast cells. (a)...
Full list of author information is available at the end of the articleBackground Thymic stromal lymp...
TSG101 depletion leads to increased levels of MMP-9 mRNA in U2OS cells. (A) Depletion of TSG101 by s...
Figure S4. Silencing TFAP2C inhibits proliferation ability of CRC cells. (A and B) Real-time PCR and...
Figure S1. Gastric cancer cell-derived conditioned medium induced pro-inflammatory factor gene expre...
Figure S2. PD-1 + CD137+ expression increases when αCSF-1R is administered before and after GVAX vac...